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Abstract
Background Cholecystectomy is the therapy of first choice in patients with uncomplicated symptomatic cholecystolithiasis, but it
remains unclear which patients truly benefit in terms of health status improvement. Patients generally present with episodic
abdominal pain of varying frequency, duration, and intensity. We assessed whether characteristics of abdominal pain episodes are
determinants of clinically relevant improvement of health status after cholecystectomy.
Methods In a post hoc analysis of a prospective multicenter cohort study, patients of ≥18 years of age with uncomplicated
symptomatic cholecystolithiasis subjected to cholecystectomy were included. Preoperatively, patients received a structured
interview and a questionnaire consisting of the visual analogue scale (VAS; range 0–100) and gastrointestinal quality of life
index (GIQLI). At 12 weeks after cholecystectomy, the GIQLI was again administered. Logistic regression analyses were
performed to determine significant associations.
Results Questionnaires were sent to 261 and returned by 166 (63.6 %) patients (128 females, mean age at surgery 49.5±13.8). A
total of 131 (78.9 %) patients reported a clinically relevant improvement of health status. The median (interquartile range)
frequency, duration, and intensity of abdominal pain episodes were 0.38 (0.18–0.75) a week, 4.00 (2.00–8.00) hours, and 92
(77–99), respectively. None of the characteristics was associated with a clinically relevant improvement of health status at
12 weeks after cholecystectomy.
Conclusions Characteristics of abdominal pain episodes cannot be used to inform patients with symptomatic cholecystolithiasis
who are skeptic about the timing of cholecystectomy for optimal benefit. Timing of cholecystectomy should therefore be based
on other characteristics and preferences.
Keywords Pain . Health status . Cholecystectomy
Introduction
Cholecystolithiasis represents a clinical spectrum that
ranges from asymptomatic gallstone disease to uncom-
plicated symptomatic gallstone disease to acute chole-
cystitis. Likewise, therapeutic options may go from con-
servative treatment to cholecystectomy. Patients with
asymptomatic cholecystolithiasis benefit least from cho-
lecystectomy in terms of improvement of health status
and should receive conservative care, whereas those
with acute cholecystitis benefit most and should receive
surgery.1–4 The optimal timing that results in the highest
benefit for patients with uncomplicated symptomatic
cholecystolithiasis remains less clear.
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Uncomplicated symptomatic cholecystolithiasis is fre-
quently characterized by abdominal pain episodes of widely
varying frequency. These episodes may last minutes or several
hours, and their intensity is variable.5 Previous studies have
shown that patients with a higher frequency of episodic ab-
dominal pain were less likely to obtain pain relief after
cholecystectomy.6
–10 Conversely, those with a typical episode
duration between 30 min and 24 h were more likely to report
absence of pain after surgery, whereas patients with a higher
pain intensity were not more likely to report absence of pain.10
Abdominal symptom characteristics may also indicate which
patients are most likely to display clinically relevant improve-
ment of patient-reported overall health status after cholecys-
tectomy: a more comprehensive outcome measure that not
only includes symptom evaluation, but also emotional, phys-
ical, and social functioning.11
We aimed to assess whether frequency, maximum duration,
or intensity of abdominal pain episodes were associated with
improvement of health status in order to define which patients
with uncomplicated symptomatic cholecystolithiasis may
benefit most from cholecystectomy. We also assessed the as-
sociations of these episode characteristics with different sub-
scales of health status at 12 weeks after cholecystectomy.
Methods
Study Sites and Patient Selection
We performed a post hoc analysis using the database
established during a previous multicenter cohort study con-
ducted in the Netherlands. Details of study design were report-
ed previously.12 In short, all individuals aged 18 years and
over with symptomatic cholelithiasis, who visited the surgical
outpatient clinic at a tertiary referral center (Radboud
University Medical Centre, Nijmegen) or one of the two
non-academic teaching hospitals (St. Elisabeth Hospital,
Tilburg and the Medisch Spectrum Twente Hospital,
Enschede) between June 2012 and June 2014, and were
scheduled for elective cholecystectomy were eligible for par-
ticipation in the study. Cholelithiasis was defined as abdomi-
nal pain associated with gallstones, confirmed with ultrasound
imaging. Medical histories were obtained by a single physi-
cian (MPL) through a structured interview.
Patients were asked to recall the duration of symptoms, the
number of episodes, and longest episode duration. Patients
with a history of symptoms for more than 1 year or who
reported to have experienced more than five episodes were
excluded, because most of these patients could not recall the
frequency. Consequently, these data were only sporadically
reported in the database. In addition, we excluded those with
schizophrenia or other mental disorders that may impair recall.
Other exclusion criteria were as follows: a history of
complicated symptomatic cholelithiasis (acute cholecystitis,
cholangitis, biliary pancreatitis, choledocholithiasis requiring
endoscopic retrograde cholangiopancreatography
(ERCP)),13,14 ASA fitness grades III and IV, insufficient
knowledge of the Dutch language, non-Dutch residency,
blindness, pregnancy, cirrhosis, or cancer treatment. Eligible
patients were asked to complete a questionnaire before chole-
cystectomy and 12 weeks after cholecystectomy. Patients who
failed to return or complete the questionnaire before and after
surgery were excluded.
The questionnaire consisted of the gastrointestinal quality
of life index (GIQLI). The GIQLI has been developed in
Germany and has been translated and validated in
Dutch.15,16 For an example of the questions and response
categories of this questionnaire, we refer to a previous study.15
The GIQLI addresses upper and lower gastrointestinal symp-
toms (19 questions), emotional (5 questions), physical (7
questions), social well-being (4 questions), and effect of med-
ical treatment (1 question) in the previous 2 weeks. Each
question contains five response categories. Questions can be
scored using a response scale ranging from 0 (worst appraisal)
to 4 points (best appraisal) for each question, giving an overall
score of 0–144 points. The higher the score, the better overall
health status is. A clinically relevant improvement after sur-
gery was defined as an increase of 5 points or more in the
overall score or in any of the subscales.17 We also included a
visual analogue score (VAS) providing a range of scores from
0 to 100 to quantify the maximum severity of pain
preoperatively.
The study was approved by the medical ethics committee
and reported in accordance with the recommendations in the
Strengthening the Reporting of Observational studies in
Epidemiology (STROBE) guidelines for reporting observa-
tional studies.18
Outcomes and Variables of Interest
The primary outcome was defined as a clinically relevant im-
provement of overall health status. Secondary outcomes in-
cluded a clinically relevant improvement of upper and lower
gastrointestinal symptoms, or on the emotional, physical, and
social subscales, respectively. Based on previous publications,
the independent variables included sex,10,19 age at opera-
tion,10,19 center,10 baseline GIQLI score,19 ASA fitness grade,
frequency, maximum duration, and intensity of abdominal
pain episodes.
Statistical Analysis
We examined whether baseline clinical and abdominal pain
characteristics differed between responders and non-
responders to the questionnaire, using χ2 tests or Fisher’s ex-
act tests for categorical data, Student’s t tests for continuous
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data, and Mann-Whitney U tests for ordinal data. We deter-
mined which variables were associated in univariable analysis
with a clinically relevant improvement of health status after
surgery using logistic regression analyses. Significant vari-
ables in univariable analysis (P<0.10) were introduced into
a backward multivariable regression model to determine
whether there were independent predictors of clinically rele-
vant improvement of overall health status or any of the sub-
scales after surgery. Age at operation, sex, center, and baseline
GIQLI score were the variables that were retained in the mod-
el as co-variables. Results were reported as adjusted odds
ratios (ORs) with corresponding 95 % confidence intervals.
P<0.05 was considered statistically significant. All missing
values were considered to be completely at random and ex-
cluded from analyses. Statistical analyses were performed
using SPSS statistical software version 20.0 (IBM, Armonk,
NY, USA).
Results
The database consisted of 870 potentially eligible patients. A
total of 261 patients were included. Preoperative and postop-
erative questionnaires were returned and completed by 166
(63.6 %) patients (Fig. 1). Baseline characteristics of the
responding patients are shown in Table 1. One hundred and
twenty-eight of the responding patients were females. Mean
age at surgery was 49.5±13.8 years. Themedian (interquartile
range) frequency, duration, and intensity of abdominal pain
episodes were 0.38 (0.18–0.75) a week, 4.00 (2.00–8.00)
hours, and 92 (77–99), respectively. Baseline and abdominal
pain characteristics did not differ between responders and
non-responders.
One hundred and thirty-one (78.9 %) patients reported an
overall clinically relevant improvement after surgery.
Univariable analysis showed maximum intensity of abdomi-
nal pain episodes to be associated with clinically relevant im-
provement of overall health status (OR 1.02, 95 % CI 1.00–
1.04; P=0.069) (Table 2). Maximum intensity of abdominal
pain episodes did not remain associated in multivariable anal-
ysis (OR 1.03, 95 % CI 1.00–1.05; P=0.066).
On the gastrointestinal symptom subscale, 105 (63.3 %)
patients reported a clinically relevant improvement
(Table 3). The emotional subscale showed a clinically relevant
improvement in 37 (22.3 %) patients. A clinically relevant im-
provement of the physical subscale was reported by 54
(32.5 %) patients. Thirty-nine (23.5 %) patients showed a clin-
ically relevant improvement of the social subscale.
Duration was associated with clinically relevant im-
provement of the physical (OR 1.07, 95 % CI 1.02–
1.12; P=0.007) and social subscales (OR 1.09, 95 %
CI 1.04–1.14; P < 0.001) in univariable analysis
(Table 3). Univariable analysis showed frequency to be
associated with clinically relevant improvement of the
social subscale (OR 2.39, 95 % CI 1.11–5.12;
P = 0.025). In multivariable analysis, duration (OR
1.10, 95 % CI, 1.03–1.17; P = 0.003) and frequency
(OR 2.95, 95 % CI 1.08–8.08; P=0.035) of abdominal
pain episodes with clinically relevant improvement of
the social subscale remained associated.
Discussion
This study showed a clinically relevant improvement of over-
all health status in 131 (78.9 %) patients at 12 weeks after
cholecystectomy. Episode characteristics of pain were not as-
sociated with an overall clinically relevant improvement of
health status after surgery, but patients with a higher frequency
and a longer duration of abdominal pain episodes were more
likely to have a clinically relevant improvement of social func-
tioning after surgery.
The preoperative health status score and improvement of
health status were similar to studies using the same patient-
reported outcomes.1
–4 We measured patient-reported out-
comes at 12 weeks after cholecystectomy as studies suggest
that the results at this time point persist at long-term follow-
up.10,20 In studies defining clinically relevant health outcome
after surgery exclusively as pain or symptom relief, abdominal
pain episode characteristics were associated with a better
outcome.6–10 We showed, however, that characteristics of ab-
dominal pain episodes were not associated with overall health
outcome when other factors such as emotional and social
functioning are also taken into account. No associations were
found between abdominal pain episode characteristics and all
the subscales of health status, except for the social subscale.
This study showed an association of increased pain episode
frequency with the social subscale of health status improve-
ment. In addition, a longer duration of pain episodes has been
associated with absence of pain,10 whereas an association was
found with clinically relevant improvement of social function-
ing in this study. The higher frequency and longer duration
may have been caused by an undetected social disabling mild
acute cholecystitis.13 This suggestion may certainly fit with
the spectrum of cholecystolithiasis.
The main explanation for the discrepant results with litera-
ture is the difference in patient-reported outcomes. The most
comprehensive patient-reported outcome measure in patients
with uncomplicated symptomatic cholecystolithiasis to deter-
mine appropriate and efficient utilization of cholecystectomy
is still under debate. Postoperative absence of pain, satisfac-
tion, and health status improvement all have been previously
used as primary patient-reported outcome measures.11
Argument for using patient-reported absence of postoperative
pain as primary outcome is that the diagnosis of uncomplicat-
ed symptomatic cholecystolithiasis is based on abdominal
1352 J Gastrointest Surg (2016) 20:1350–1358
pain.21–23 In addition, postoperative pain after cholecystecto-
my is the main predictor of a patient-reported unsuccessful
outcome.24 Satisfaction as primary outcome has the advantage
of providing information about the relationship between
Fig. 1 Flow chart showing
inclusion of patients in the study
Table 1 Characteristics of the
responding and non-responders to
the questionnaires
Characteristic Responders, n= 166 Non-responders, n= 95 P value
Age (years) 49.5 ± 13.8 46.3 ± 16.3 0.09
Sex 0.81
Male 38 (22.9) 23 (24.2)
Female 128 (77.1) 72 (75.8)
ASA fitness grade 0.46
I 83 (50.0) 52 (54.7)
II 83 (50.0) 43 (45.3)
Center
Radboud UMC 36 (21.7) 19 (20.0) NA
MST 69 (41.6) 47 (49.5) NA
St Elisabeth Hospital 61 (36.7) 29 (32.2) NA
Frequency of abdominal pain
episodes a week
0.4 (0.2–0.8) 0.3 (0.2–0.7) 0.65
Duration of longest abdominal
pain episode in hours
4.0 (2.0–8.0) 4.0 (2.0–6.3) 0.48
Maximum intensity of pain
episode ranging 0–100
92 (77–99) NA
Baseline GIQLI score 103.5 ± 22.1 NA
GIQLI score 12 weeks after
cholecystectomy
124.4 ± 13.7 NA
Data are expressed as mean (standard deviation) or n (%) or median (interquartile range)
ASA American Society of Anesthesiologists, GIQLI gastrointestinal quality of life index, UMC University
Medical Center, NA not applicable, MSTMedisch Spectrum Twente hospital
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patient expectations and the treatment experience. Satisfaction
incorporates the description of healthcare from the patient’s
viewpoint, measurement of the process of care, and evaluation
of its outcome.11 Finally, argument for using health status
improvement is that it measures various domains of health
and on a continuous scale. This outcome allows us to deter-
mine which patient benefits most from therapy.11 Health status
improvement was therefore chosen as primary patient-
reported outcome in this study.
Our study has some limitations. First, we cannot fully rule
out recall bias, although we limited this type of bias by ex-
cluding patients that could not recall abdominal pain frequen-
cy. The generalizability of the results may therefore be limited,
although the patient characteristics are no different compared
with the characteristics of other studies.5–10 Second, the inclu-
sion of referred patients and the limited response rate may
have caused selection bias, although we did not find any sig-
nificant differences between the responding and non-
responding patients. Third, we performed a post hoc analysis
using a database of a previous multicenter cohort study. A
formal power analysis was therefore not conducted. Finally,
the natural course of symptoms,25,26 placebo effect of sur-
gery,27 or expectancy of patients28 may have biased the ques-
tionnaire answers. Concerning the wax and waning of abdom-
inal pain episodes,5 we corrected for preoperative health
status. Unfortunately, randomized trials to limit biased ques-
tionnaire answers were prohibited due to ethical reasons.
This study included several strengths as well. First, the data-
base of a prospective observational study was used limiting
confounding bias. Second, we used a standardized and validated
questionnaire allowing reliable comparisons with other studies
using this widely translated and validated questionnaire.15,16
Third, using a single interviewer in all three centers excluded
interobserver bias. Finally, patients were recruited from both
tertiary and general hospitals increasing the generalizability.
Since patients that benefit most in terms of health status
improvement cannot be predicted using abdominal pain epi-
sode characteristics, future studies should assess which un-
complicated symptomatic cholecystolithiasis patients are at
increased risk for complicated cholecystolithiasis. Although
the risk of complications because of gallstones in uncompli-
cated symptomatic cholecystolithiasis patients is estimated to
be only 1–3 % a year, these complications can be serious and
life threatening as previously reported in this journal.29,30
Preventing uncomplicated symptomatic cholecystolithiasis pa-
tients to proceed to complicated symptomatic cholecystolithiasis
by early cholecystectomy would increase the cost-effectiveness
of this common surgical procedure.
In conclusion, frequency, maximum duration, and intensity
of abdominal pain episodes are not associated with a patient-
Table 2 Univariable and multivariable association of pain episode characteristics with patient-reported minimal clinically important improvement of
health status
Clinically relevant improvement Univariable analysis Multivariable analysis
<5 points on GIQLI,
n = 35
≥5 points on GIQLI,
n= 131
Odds ratio (95 % CI) P value Odds ratio (95 % CI) P value
Age (years) 50.6 ± 13.6 49.2 ± 13.9 0.99 (0.97–1.02) 0.586 1.0 (0.96–1.04) 0.885
Sex 0.179 0.650
Female 24 (68.6) 104 (79.4) 1.77 (0.77–4.05) 0.76 (0.24–2.46)
Male 11 (31.4) 27 (20.6) 1.00 (reference)
Hospital type 0.850 0.812
Tertiary referral center 8 (22.9) 28 (21.4) 0.92 (0.38–2.24) 0.86 (0.24–3.06)
Non-academic 27 (77.1) 103 (78.6) 1.00 (reference)
Baseline GIQLI score 126.6 ± 11.8 97.3 ± 20.0 0.88 (0.84–0.92) <0.001 0.88 (0.84–0.92) <0.001
ASA fitness grade 0.568
II 16 (45.7) 67 (51.1) 1.24 (0.59–2.63)
I 19 (54.3) 64 (48.8) 1.00 (reference)
Frequency of pain episodes
a week
0.4 (0.2–0.5) 0.4 (0.2–1.0) 1.66 (0.65–4.26) 0.287
Maximum duration of
longest pain episode in
hours
4.0 (2.5–9.0) 4.0 (2.0–8.0) 1.01 (0.96–1.07) 0.648
Maximum intensity of pain
episode ranging 0–100
88.5 (72.0–94.3) 93.5 (79.0–99.8) 1.02 (1.00–1.04) 0.069 1.03 (1.00–1.05) 0.066
Data are expressed as mean (standard deviation) or n (%) or median (interquartile range)
95% CI, 95 % confidence interval, ASA American Society of Anesthesiologists, GIQLI gastrointestinal quality of life index
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reported clinically relevant improvement of health status at
12 weeks after cholecystectomy. Characteristics of abdominal
pain episodes cannot be used to inform patients with symp-
tomatic cholecystolithiasis who are skeptic about the timing of
cholecystectomy for optimal benefit. Timing of cholecystec-
tomy for these patients should therefore be based on other
characteristics and preferences.
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